Evan Black, MD
Neurology · Murray, UTNPI 1346260247
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,114 of the $14,572 with a category attached, or 62.5%. Teva Pharmaceuticals USA, Inc. accounts for 93.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $14,301 and has fallen 99.2% since, to $115 in 2021.
Across 82 payments — averaging $177.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$14K
- Sanofi$202
- EMD Serono, Inc.$132
- Boston Scientific$115
- Novartis$97
- AstraZeneca$54
- plus $313 from 10 others
What the payments were for
- Consulting fees$2,50017%
- Speaking & faculty fees$9,11463%
- Travel & lodging$1,43510%
- Food & beverage$1,52310%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $13,659 |
| Sanofi | 12 | $202 |
| EMD Serono, Inc. | 15 | $132 |
| Boston Scientific | 1 | $115 |
| Novartis | 7 | $97 |
| AstraZeneca | 4 | $54 |
| Amgen | 3 | $48 |
| Biogen | 3 | $41 |
| Lilly USA, LLC | 3 | $41 |
| Livanova USA, Inc. | 2 | $34 |
| Acadia Pharmaceuticals Inc | 2 | $31 |
| Johnson & Johnson | 2 | $30 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Lundbeck LLC | 1 | $24 |
| UCB, Inc. | 2 | $23 |
| Acorda Therapeutics, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,572 in reported general payments places this provider in the 80th percentile of 157 neurology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Murray
- Nigel HarrisonMurray$41K
- Michael HunterMurray$33K
- Heston ArnoldMurray$20K
- Maya ThomasMurray$3K
- Kathleen McKeeMurray$3K
- Timothy WestSalt Lake City$856K
- Richard HammondOgden$707K
- Jeffrey GrovesDraper$628K
- Stacey SteevesSalt Lake City$548K
- Amir ArainSalt Lake City$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.